![](https://testing.innoplexus.com/wp-content/plugins/relevant/images/no_preview.jpg)
Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
Ontosight® – Biweekly NewsletterJune 17th – June 30th, 2024 –Read More
May 24
Apr 24
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read MoreThis is the talk given by Innoplexus Co-founder & CTO, Mr. Gaurav Tripathi at DataHack 2018 – an event by Analytics Vidhya.
Lot of analytics companies from silicon valley to budding startups are targeting to solve the problem of drug discovery to suggesting prescriptions. But would you really trust a cancer medicine suggested by a software program?
AI today is at a level of doing lower cognitive tasks such as aggregating numbers, finding patterns, suggesting correlations rather than understanding human level intelligence of thoughts, implications or emotions. That is why it should be used to solve the time-consuming and mundane problems leaving the quick and theoretically complex decisions to the judgement of the experts such as doctors, making it win-win for everyone.
Here, Gaurav would talk about three AI technologies Innoplexus has developed to cut down drug development time at all stages and how should one pursue the field to facilitate traditional institutions for patient care.
Evolutionary learning based Incremental crawling
Computer vision based information comprehension
Ontology-based life sciences language processing
This video originally published on youtube channel of Analytics Vidhya.
Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF…
During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the…
Frankfurt, Germany; 14 March 2024 Partex Group, a pioneer in AI-driven drug discovery, today announces a collaboration with global pharmaceutical…
January 02, 2024 – Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health…
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…